Comparison
Gimme vs Mochi Health
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Gimme | Mochi Health | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $163/mo (3-mo prepay) | from $278/mo (monthly plan) |
| Semaglutide price | from $130/mo (3-mo prepay) | from $165/mo (3-mo prepay) |
| Pharmacy receipt | Fills through Align Pharmacy, Apothecary Pharma +4 per market data — Apothecary Pharma, BPI Labs are FDA-registered 503B outsourcing facilities (federal cGMP oversight). Pick your state to check the rest. | Fills through DCA Pharmacy, Empower +2 per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest. |
| Care receipt | Care is outsourced to Bask Telehealth — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. | Outsourced contract clinicians — the brand doesn't employ your clinician — with check-ins and coaching on record. |
| Review integrity | Review-integrity flag — 89% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. | Clean review record — 5% unprompted on 4,934 reviews, within our 40% threshold. |
| Company address | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. | Lists a real-looking operating address on its own site. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | 50 states | 50 states |
| Pharmacy model | Telehealth platform that connects patients with licensed prescribers and routes prescriptions to compounding pharmacies for fulfillment. Sells compounded semaglutide and compounded tirzepatide (injectable). The site states these are made by 'highly regulated' U.S. pharmacies but that 'the FDA has not evaluated the medications for safety, quality, or efficacy.' Brand products (Mounjaro, Zepbound) are noted as not compounded. | Marketplace model: Mochi routes prescriptions to a network of compounding pharmacies and says patients pick a partner pharmacy in the patient portal. Mochi does not publish a full list of its partner pharmacies. One reported affiliated pharmacy, Aequita Pharmacy of Kirkland, WA, was subject to a Washington State Limited Stop Service in March 2025 and reportedly closed in April 2025. |
| Red flags on file | 2 | 3 |
Visit gimme.care
Plain link, not sponsored — we take no payment for this.
Full profiles: Gimme → · Mochi Health →
State-aware license reads: the tirzepatide price board →